Cargando…
The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age
BACKGROUND: Fluticasone propionate 50 μg/salmeterol xinafoate 25 μg (FP/SAL) is widely used in adults and children with asthma, but there is sparse information on its use in very young children. METHODS: This was a randomized, double‐blind, multicentre, controlled trial conducted in children aged 8 ...
Autores principales: | Yoshihara, Shigemi, Tsubaki, Toshikazu, Ikeda, Masanori, Lenney, Warren, Tomiak, Richard, Hattori, Takako, Hashimoto, Kenichi, Soutome, Toru, Kato, Shihona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850202/ https://www.ncbi.nlm.nih.gov/pubmed/30556939 http://dx.doi.org/10.1111/pai.13010 |
Ejemplares similares
-
Salmeterol/fluticasone combination in the treatment of COPD
por: Chung, K F
Publicado: (2006) -
Evaluation of Fluticasone Propionate and Fluticasone Propionate/Salmeterol Combination on Exercise in Pediatric and Adolescent Patients with Asthma
por: Murray, John J, et al.
Publicado: (2011) -
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
por: Houghton, Catherine M, et al.
Publicado: (2007) -
Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
por: Tamura, Tomohiro, et al.
Publicado: (2016) -
Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalation
por: Sunwoo, Jung, et al.
Publicado: (2017)